Type 3 Inositol 1,4,5‐Trisphosphate Receptor Is Increased and Enhances Malignant Properties in Cholangiocarcinoma-Reference-Cited by-同舟云学术

Type 3 Inositol 1,4,5‐Trisphosphate Receptor Is Increased and Enhances Malignant Properties in Cholangiocarcinoma

Published:2019-08-19 Issue:2 Volume:71 Page:583-599
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Ueasilamongkol Pimwipa¹,Khamphaya Tanaporn²,Guerra Mateus T.³,Rodrigues Michele A.³,Gomes Dawidson A.³,Kong Yong⁴,Wei Wei⁴,Jain Dhanpat⁵,Trampert David C.³,Ananthanarayanan Meenakshisundaram³,Banales Jesus M.⁶,Roberts Lewis R.⁷,Farshidfar Farshad⁸⁹,Nathanson Michael H.³,Weerachayaphorn Jittima¹³

Affiliation:

1. Department of Physiology, Faculty of Science Mahidol University Bangkok Thailand

2. Toxicology Graduate Program, Faculty of Science Mahidol University Bangkok Thailand

3. Section of Digestive Diseases Yale University School of Medicine New Haven CT

4. Department of Biostatistics Yale University School of Public Health New Haven CT

5. Department of Pathology Yale University School of Medicine New Haven CT

6. Department of Liver and Gastrointestinal Diseases Biodonostia Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), CIBERehd, Ikerbasque San Sebastian Spain

7. Divisions of Gastroenterology and Hepatology and Laboratory Medicine and Pathology Mayo Clinic College of Medicine Rochester MN

8. Department of Oncology, Cumming School of Medicine University of Calgary Calgary Canada

9. Arnie Charbonneau Cancer Institute University of Calgary Calgary Canada

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

National Cancer Institute

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.30839